Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China flag China · Delayed Price · Currency is CNY
18.08
+0.92 (5.36%)
Feb 3, 2026, 3:04 PM CST

SHE:300401 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
1,2191,2211,0821,3971,107650.39
Other Revenue
22.4522.4512.9320.399.759.05
1,2411,2431,0951,4181,117659.44
Revenue Growth (YoY)
9.43%13.58%-22.78%26.89%69.40%-8.21%
Cost of Revenue
546.12519.59441.4486.37350.66281.47
Gross Profit
695.27723.7653.25931.14766.44377.97
Selling, General & Admin
263.14308.87378.77444.55257.6193.3
Research & Development
71.3383.7890.9170.3459.2845.09
Other Operating Expenses
21.1713.2416.4416.243.485.61
Operating Expenses
356.92407.87483.74533.66320.69144.04
Operating Income
338.35315.83169.51397.48445.75233.93
Interest Expense
-31-35.63-38.41-21.82-10.81-16.91
Interest & Investment Income
9.2811.0120.5413.7532.4926.87
Currency Exchange Gain (Loss)
6.316.317.0211.1-2.79-7.22
Other Non Operating Income (Expenses)
-1.16-0.32-0.3-0.65-0.19-0.25
EBT Excluding Unusual Items
321.78297.19158.36399.86464.46236.42
Gain (Loss) on Sale of Investments
2.880.25-0.34-2.830.4-
Gain (Loss) on Sale of Assets
-3.7831.53-0.0417.876.220.02
Asset Writedown
-2.81-0.44-0.22-1.01-0.09-0.43
Other Unusual Items
36.1930.1753.2728.6748.3851.7
Pretax Income
354.26358.69211.04442.48589.37287.71
Income Tax Expense
52.4749.4818.758.7675.4227.09
Earnings From Continuing Operations
301.8309.21192.35383.72513.94260.62
Minority Interest in Earnings
0.010---30.182.6
Net Income
301.8309.21192.35383.72483.77263.22
Net Income to Common
301.8309.21192.35383.72483.77263.22
Net Income Growth
5.94%60.76%-49.87%-20.68%83.79%-23.42%
Shares Outstanding (Basic)
548542550548544506
Shares Outstanding (Diluted)
581595601548544506
Shares Change (YoY)
-9.28%-1.07%9.65%0.85%7.38%6.04%
EPS (Basic)
0.550.570.350.700.890.52
EPS (Diluted)
0.520.520.320.700.890.52
EPS Growth
16.77%62.50%-54.29%-21.35%71.15%-27.78%
Free Cash Flow
103.29-13.97-84.57-2.89-203.33-166.46
Free Cash Flow Per Share
0.18-0.02-0.14-0.01-0.37-0.33
Dividend Per Share
0.1140.1140.0710.1400.1880.103
Dividend Growth
60.56%60.56%-49.29%-25.53%82.52%-
Gross Margin
56.01%58.21%59.68%65.69%68.61%57.32%
Operating Margin
27.26%25.40%15.48%28.04%39.90%35.47%
Profit Margin
24.31%24.87%17.57%27.07%43.31%39.91%
Free Cash Flow Margin
8.32%-1.12%-7.72%-0.20%-18.20%-25.24%
EBITDA
510.53471.35302.82458.27490.2279.59
EBITDA Margin
41.13%37.91%27.66%32.33%43.88%42.40%
D&A For EBITDA
172.18155.52133.3160.7944.4545.66
EBIT
338.35315.83169.51397.48445.75233.93
EBIT Margin
27.26%25.40%15.48%28.04%39.90%35.47%
Effective Tax Rate
14.81%13.80%8.86%13.28%12.80%9.41%
Revenue as Reported
1,2411,2431,0951,4181,117659.44
Advertising Expenses
-2.370.970.70.81.13
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.